阿库斯生物科学 RCUS
$18.28 +$0.59 (+3.34%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $18.28 0.00%
开盘$17.95
昨收$17.69
当日区间$17.51 – $18.50
成交量1.06M
市值$2.63B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$41.00M-74.4% YoY
营业利润-$96.00M-1,100.0% YoY
净利润-$91.00M
摊薄每股收益-$0.72
自由现金流-$119.00M+10.5% YoY
经营现金流-$119.00M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-415.4%
净利率-393.2%
净资产收益率-90.8%
资产收益率-46.0%
投入资本回报率-78.6%
流动比率3.82
负债/资产比率49.8%
现金及投资$702.00M
总负债$101.00M
净现金（净负债）$601.00M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $41.00M | $17.00M | $247.00M | $33.00M | $26.00M |
| 营业总收入 | $41.00M | $17.00M | $247.00M | $33.00M | $26.00M |
| 营业费用 | $137.00M | $151.00M | $633.00M | $147.00M | $168.00M |
| 销售及管理费用 | $24.00M | $29.00M | $110.00M | $26.00M | $27.00M |
| -管理费用 | $24.00M | $29.00M | $110.00M | $26.00M | $27.00M |
| 研发费用 | $113.00M | $122.00M | $523.00M | $121.00M | $141.00M |
| 营业利润 | -$96.00M | -$134.00M | -$386.00M | -$114.00M | -$142.00M |
| 非经营性利息净收入（支出） | $5.00M | $6.00M | $33.00M | $8.00M | $7.00M |
| 非经营性利息收入 | $8.00M | $9.00M | $41.00M | $10.00M | $10.00M |
| 非经营性利息支出 | $3.00M | $3.00M | $8.00M | $2.00M | $3.00M |
| 税前利润 | -$91.00M | -$128.00M | -$353.00M | -$106.00M | -$135.00M |
| 税费 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 净利润 | -$91.00M | -$128.00M | -$353.00M | -$106.00M | -$135.00M |
| 持续经营利润 | -$91.00M | -$128.00M | -$353.00M | -$106.00M | -$135.00M |
| 归属母公司净利润 | -$91.00M | -$128.00M | -$353.00M | -$106.00M | -$135.00M |
| 归属普通股股东净利润 | -$91.00M | -$128.00M | -$353.00M | -$106.00M | -$135.00M |
| 基本每股收益 | -$0.72 | -$1.02 | -$3.29 | -$0.89 | -$1.27 |
| 摊薄每股收益 | -$0.72 | -$1.02 | -$3.29 | -$0.89 | -$1.27 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| -减：资本性资产减值 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $924.00M | $997.00M | $1.14B | $1.14B | $974.00M |
| 流动资产合计 | $756.00M | $844.00M | $1.01B | $1.01B | $857.00M |
| 现金及现金等价物与短期投资 | $702.00M | $822.00M | $981.00M | $981.00M | $831.00M |
| -现金及现金等价物 | $150.00M | $201.00M | $222.00M | $222.00M | $238.00M |
| -短期投资 | $552.00M | $621.00M | $759.00M | $759.00M | $593.00M |
| 应收款 | $41.00M | $7.00M | $16.00M | $16.00M | $14.00M |
| -应收账款 | $36.00M | $3.00M | $11.00M | $11.00M | $11.00M |
| -应计应收利息 | $5.00M | $4.00M | $5.00M | $5.00M | $3.00M |
| 其他流动资产 | $13.00M | $15.00M | $10.00M | $10.00M | $12.00M |
| 非流动资产合计 | $168.00M | $153.00M | $132.00M | $132.00M | $117.00M |
| 固定资产净值 | $36.00M | $38.00M | $40.00M | $40.00M | $42.00M |
| -固定资产原值 | $36.00M | $38.00M | $90.00M | $90.00M | – |
| 投资及预付款 | $73.00M | $54.00M | $29.00M | $29.00M | $10.00M |
| -可供出售证券 | $73.00M | $54.00M | $29.00M | $29.00M | $10.00M |
| 其他非流动资产 | $59.00M | $61.00M | $63.00M | $63.00M | $65.00M |
| 负债合计 | $460.00M | $473.00M | $508.00M | $508.00M | $538.00M |
| 流动负债合计 | $198.00M | $209.00M | $231.00M | $231.00M | $235.00M |
| 应付款 | $35.00M | $40.00M | $43.00M | $43.00M | $42.00M |
| -应付账款 | $34.00M | $39.00M | $42.00M | $42.00M | $42.00M |
| -应付税款合计 | $1.00M | $1.00M | $1.00M | $1.00M | – |
| 一年内应计费用 | $119.00M | $112.00M | $122.00M | $122.00M | $112.00M |
| 短期债务及融资租赁负债 | $13.00M | $13.00M | $13.00M | $13.00M | $13.00M |
| -一年内到期融资租赁负债 | $13.00M | $13.00M | $13.00M | $13.00M | $13.00M |
| 一年内递延负债 | $19.00M | $34.00M | $35.00M | $35.00M | $52.00M |
| 其他流动负债 | $12.00M | $10.00M | $18.00M | $18.00M | $16.00M |
| 非流动负债合计 | $262.00M | $264.00M | $277.00M | $277.00M | $303.00M |
| 长期债务及融资租赁负债 | $101.00M | $100.00M | $99.00M | $99.00M | $98.00M |
| -长期债务 | $101.00M | $100.00M | $99.00M | $99.00M | $98.00M |
| 一年以上递延负债 | $37.00M | $45.00M | $43.00M | $43.00M | $53.00M |
| 其他非流动负债 | $124.00M | $119.00M | $135.00M | $135.00M | $152.00M |
| 股东权益合计 | $464.00M | $524.00M | $631.00M | $631.00M | $436.00M |
| 股东权益 | $464.00M | $524.00M | $631.00M | $631.00M | $436.00M |
| 股本 | $2.17B | $2.14B | $2.12B | $2.12B | $1.82B |
| -普通股 | $2.17B | $2.14B | $2.12B | $2.12B | $1.82B |
| 留存收益 | -$1.70B | -$1.61B | -$1.49B | -$1.49B | -$1.38B |
| 不影响留存收益的损益 | -$1.00M | -$1.00M | – | – | – |
| -累计折旧 | – | – | -$50.00M | -$50.00M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$119.00M | -$138.00M | -$482.00M | -$120.00M | -$97.00M |
| 持续经营经营活动现金流净额 | -$119.00M | -$138.00M | -$482.00M | -$120.00M | -$97.00M |
| 持续经营净利润 | -$91.00M | -$128.00M | -$353.00M | -$106.00M | -$135.00M |
| 折旧、折耗与摊销 | $3.00M | $2.00M | $10.00M | $3.00M | $2.00M |
| 其他非现金项目 | $4.00M | $2.00M | $8.00M | $1.00M | $4.00M |
| 营运资金变动 | -$47.00M | -$31.00M | -$194.00M | -$30.00M | $21.00M |
| -应收款变动 | -$3.00M | $8.00M | $9.00M | $0.00 | $4.00M |
| -应付账款及应计费用变动 | -$5.00M | -$3.00M | $24.00M | $0.00 | $13.00M |
| -其他流动资产变动 | $0.00 | -$3.00M | $5.00M | $0.00 | $6.00M |
| -其他流动负债变动 | -$2.00M | -$16.00M | $8.00M | -$4.00M | $24.00M |
| -其他营运资金变动 | -$37.00M | -$17.00M | -$240.00M | -$26.00M | -$26.00M |
| 投资活动现金流净额 | $52.00M | $114.00M | $66.00M | -$182.00M | $79.00M |
| 持续经营投资活动现金流净额 | $52.00M | $114.00M | $66.00M | -$182.00M | $79.00M |
| 固定资产购置及出售净额 | $0.00 | $0.00 | -$2.00M | -$1.00M | $0.00 |
| 投资购置及出售净额 | $52.00M | $114.00M | $68.00M | -$181.00M | $79.00M |
| 筹资活动现金流 | $16.00M | $3.00M | $488.00M | $286.00M | $8.00M |
| 持续经营筹资活动现金流净额 | $16.00M | $3.00M | $488.00M | $286.00M | $8.00M |
| 普通股发行净额 | $0.00 | $0.00 | $429.00M | $279.00M | $8.00M |
| 股票期权行使所得 | $16.00M | $3.00M | $10.00M | $7.00M | $0.00 |
| 期末现金余额 | $153.00M | $204.00M | $225.00M | $225.00M | $241.00M |
| 现金净变动 | -$51.00M | -$21.00M | $72.00M | -$16.00M | -$10.00M |
| 期初现金余额 | $204.00M | $225.00M | $153.00M | $241.00M | $251.00M |
| 自由现金流 | -$119.00M | -$138.00M | -$484.00M | -$121.00M | -$97.00M |
| 债务发行及偿还净额 | – | – | $49.00M | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 RCUS。
登录后参与讨论。